OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS

All amounts in this press release are in Canadian dollars.

QUÉBEC CITY, Nov. 2, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX:OPS.TO) (OTCQX: OPSSF) announces that the Québec Superior Court (the "Court") issued an interim order (the "Interim Order") on October 31, 2023 in connection with the previously announced acquisition by Haemonetics Corporation ("Haemonetics") (NYSE:HAE), a global healthcare company, and 9500-7704 Québec Inc., a wholly-owned subsidiary of Haemonetics ("AcquireCo" and, collectively with Haemonetics, the "Purchaser Parties") of all of the issued and outstanding common shares in the capital of OpSens (the "Shares") for $2.90 in cash per Share, pursuant to a statutory plan of arrangement (the "Arrangement") under the Business Corporations Act (Québec). Among other things, the Interim Order authorizes the Corporation to call, hold and conduct a special meeting (the "Meeting") of holders (the "Shareholders") of Shares to consider the Arrangement.